- SENIOR FACULTY Preventive Medicine
- Clinical Preventive Medicine
- Musculoskeletal, Neuro
- Preventive Medicine
- Travel Medicine
MD, Boston University Medical Center
Internship, Internal Medicine
Residency, Occupational Medicine
University of Pennsylvania
Madelynn Azar-Cavanagh, MD, MPH, FACOEM serves as the Medical Director of Employee Health, Safety and Wellness for the Mount Sinai Health System as well as the Medical Director of the Selikoff Centers for Occupational Health in the Department of Preventive Medicine at the Icahn School of Medicine. Dr. Azar-Cavanagh is a highly acclaimed physician who brings an interdisciplinary approach to the prevention, diagnosis and treatment of occupational injuries and illnesses.
She joins the Mount Sinai team from the University of California in San Diego where she led Employee Health and Wellness for both the UC San Diego Health System and the UC San Diego Campus.
Dr. Azar-Cavanagh was named as one of San Diego Magazine’s Top Doctors in Occupational Medicine in 2004 & 2005 and “America’s Top Physicians” 2004, 2005, 2009, 2010, 2011, 2012 & 2013 in Occupational Medicine. She also received the “2010 Integrity in Workers’ Comp Award” for California Physicians.
A recognized leader in Occupational and Environmental Medicine, Dr. Azar-Cavanagh will be a key advocate for the significant enrichment of workplace safety and employee wellness initiatives organization wide. To this end, she will collaborate with organizational leadership, Mount Sinai’s vast clinical resources and others to develop a framework for “Best Practices” that improves the overall coordinated health, safety and wellness of faculty and staff.
Azar-Cavanagh M, Burdt P, Green-McKenzie J. Effect of the introduction of an engineered sharps injury prevention device on the percutaneous injury rate in healthcare workers. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2007 Feb; 28(2).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Azar-Cavanagh did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Residential Tower Floor 3rd Floor, West Tower Room D3-111
10 East 102nd Street
New York, NY 10029
1468 Madison Avenue
Annenberg Building, 3rd Floor
New York, NY 10029
- Worker's Compensation